BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 558577)

  • 21. Maternal and amniotic fluid 17 alpha-hydroxyprogesterone levels during pregnancy: diagnosis of congenital adrenal hyperplasia in utero.
    Nagamani M; McDonough PG; Ellegood JO; Mahesh VB
    Am J Obstet Gynecol; 1978 Apr; 130(7):791-4. PubMed ID: 637103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful prenatal treatment of congenital adrenal hyperplasia resulting from the 21-hydroxylase deficiency: is prenatal diagnosis in a mother at risk essential?
    Romer TE; Ginalska-Malinowska M
    Endokrynol Pol; 1987; 38(1):125-30. PubMed ID: 3428229
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prenatal diagnosis of congenital adrenal hyperplasia due to a 21-hydroxylase defect--determination of 17-hydroxyprogesterone in the amniotic fluid].
    Dumić M; Plavsić V; Ille J; Brkljacić L; Drazanćić A; Suchanek E; Kaśtelan A
    Lijec Vjesn; 1987; 109(2-3):65-7. PubMed ID: 3496509
    [No Abstract]   [Full Text] [Related]  

  • 24. Significance of opaque discolored amniotic fluid at second-trimester amniocentesis.
    Hess LW; Anderson RL; Golbus MS
    Obstet Gynecol; 1986 Jan; 67(1):44-6. PubMed ID: 3940336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA and congenital adrenal hyperplasia linkage confirmed.
    Lancet; 1978 Apr; 1(8070):930-2. PubMed ID: 76861
    [No Abstract]   [Full Text] [Related]  

  • 26. Intelligence of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, their parents and unaffected siblings.
    Wenzel U; Schneider M; Zachmann M; Knorr-Mürset G; Weber A; Prader A
    Helv Paediatr Acta; 1978 Apr; 33(1):11-6. PubMed ID: 669967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The usefulness of the level of alpha-fetoprotein (AFP) and electrophoresis of amniotic acetylcholinesterase for the detection of selected congenital malformations].
    Lemonnier MC; Julian C; Aymé S; Philip N; Voeckel MA; Gamerre M; Mattéi JF
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(3):280-4. PubMed ID: 1693158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary 21-deoxycortisol and 17-hydroxyprogesterone in congenital adrenal hyperplasia.
    Milewicz A; Vecsei P; Gruszka S; Bednarek-Tupikowska G; Szymczak J; Grabiński M
    Mater Med Pol; 1984; 16(2-4):91-4. PubMed ID: 6335995
    [No Abstract]   [Full Text] [Related]  

  • 29. [Determination of 17-hydroxyprogesterone in the amniotic fluid: clinical significance].
    Catalano D; Valentino R; Troncone MG; Daniele F; Rullo F
    Arch Ostet Ginecol; 1981; 86(5-6):189-94. PubMed ID: 7349743
    [No Abstract]   [Full Text] [Related]  

  • 30. [Alpha fetoprotein and zinc in the amniotic fluid and fetal malformations].
    Rolfini G; Orrù R; Palma E; Giudiceandrea LM; Parracino C
    Clin Ter; 1987 Nov; 123(3):215-7. PubMed ID: 2460281
    [No Abstract]   [Full Text] [Related]  

  • 31. Amniotic fluid concentrations of delta 5 and delta 4 steroids in fetuses with congenital adrenal hyperplasia due to 21 hydroxylase deficiency and in anencephalic fetuses.
    Pang S; Levine LS; Cederqvist LL; Fuentes M; Riccardi VM; Holcombe JH; Nitowsky HM; Sachs G; Anderson CE; Duchon MA; Owens R; Merkatz I; New MI
    J Clin Endocrinol Metab; 1980 Aug; 51(2):223-9. PubMed ID: 6447160
    [No Abstract]   [Full Text] [Related]  

  • 32. 11-deoxycortisol in amniotic fluid: prenatal diagnosis of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency.
    Schumert Z; Rosenmann A; Landau H; Rösler A
    Clin Endocrinol (Oxf); 1980 Mar; 12(3):257-60. PubMed ID: 6966984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical forms of congenital adrenal hyperplasia in the light of recent studies].
    Sendrail M; Gleizes L; Chkili T; Vassal D
    Maroc Med; 1971 Mar; 51(544):147-55. PubMed ID: 4934951
    [No Abstract]   [Full Text] [Related]  

  • 34. [Congenital adrenocortical hyperplasia and its concept].
    Miura K
    Nihon Rinsho; 1972 Jul; 30(7):1492-8. PubMed ID: 4565285
    [No Abstract]   [Full Text] [Related]  

  • 35. [Morphologic study of amniotic fluid cells in mid-term pregnancy].
    Tóth S; Osztovics M
    Orv Hetil; 1984 Mar; 125(13):757-61. PubMed ID: 6709340
    [No Abstract]   [Full Text] [Related]  

  • 36. [Primary aldosteronism].
    Veyrat R; Grandchamp A; Scholer D; Muller AF
    Schweiz Med Wochenschr; 1970 Oct; 100(40):1671-7. PubMed ID: 5524978
    [No Abstract]   [Full Text] [Related]  

  • 37. [Alpha-fetoprotein in the amniotic fluid in pregnancies at high risk for congenital fetal defect and Rh isoimmunization].
    Brambati B; Ferrari E; Mariani V; Bonacchi I; Bonsignore L; Dambrosio F
    Ann Ostet Ginecol Med Perinat; 1981; 102(2):75-83. PubMed ID: 6167189
    [No Abstract]   [Full Text] [Related]  

  • 38. HLA typing of amniotic-fluid cells applied to prenatal diagnosis of congenital adrenal hyperplasia.
    Couillin P; Nicolas H; Boué J; Boué A
    Lancet; 1979 May; 1(8125):1076. PubMed ID: 86789
    [No Abstract]   [Full Text] [Related]  

  • 39. Prenatal diagnosis of hypophosphatasia.
    Benzie R; Doran TA; Escoffery W; Gardner HA; Hoar DI; Hunter A; Malone R; Miskin M; Rudd NL
    Birth Defects Orig Artic Ser; 1976; 12(6):271-82. PubMed ID: 974250
    [No Abstract]   [Full Text] [Related]  

  • 40. [Amniotic creatinine levels as a function of maternal and fetal pathology].
    Plotti G; Castaldo F; Guariglia L; Ferrazzani S; Garzetti GG; Cataldi L; Moneta E
    Ann Ostet Ginecol Med Perinat; 1981; 102(6):441-5. PubMed ID: 7337351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.